News & Analysis as of

New Regulations Regulatory Oversight Regulatory Reform

BakerHostetler

[Podcast] 2025 DSIR Deeper Dive: Artificial Intelligence

BakerHostetler on

We’re back with a deeper dive into the 2025 Data Security Incident Response Report, which features insights and metrics from more than 1,250 incidents in 2024. This episode dives into AI law, regulation, and guidance from...more

A&O Shearman

UK PSR Publishes Annual Report and Accounts for 2024/25

A&O Shearman on

The UK Payment Systems Regulator (PSR) has published its annual report and accounts for 2024/25, summarising the PSR's progress across its key activities over the year. In March, the UK government announced that the PSR would...more

A&O Shearman

Delegated Regulations Bringing CTPs Into Scope of ESMA Rules for DRSP Fines and Fees Published in OJ

A&O Shearman on

Delegated Regulation (EU) 2025/1768 and Delegated Regulation (EU) 2025/884 have been published in the Official Journal of the European Union (OJ), extending the scope of rules on fines and fees for data reporting service...more

Polsinelli

Navigating the Grantmaking Maze: A New Federal Oversight Framework

Polsinelli on

In a significant move to reshape the landscape of federal grantmaking, the recently issued Executive Order, “Improving Oversight of Federal Grantmaking,” is poised to transform how federal agencies administer grants. With the...more

Akin Gump Strauss Hauer & Feld LLP

Euro(re)vision: EU Revising its PFAS Restriction Proposal

On August 20, 2025, Denmark, Germany, the Netherlands, Norway and Sweden submitted an update to the proposal to restrict PFAS under the European Union’s REACH regulation that they originally submitted in January 2023. The...more

Orrick, Herrington & Sutcliffe LLP

FDA’s “Radical Transparency” Arrives: Real-Time Publication of CRLs Poses New Exposures for Innovative Pharmaceutical Companies

The U.S. Food and Drug Administration (FDA) has unveiled a sweeping transparency initiative that will fundamentally change how innovative drug and biologic developers interface with the Agency and the market. ...more

Holland & Knight LLP

Superintendencia Financiera de Colombia busca fortalecer la liquidez en mercados de capitales

Holland & Knight LLP on

Por medio del Proyecto No. 15 de 2025 la Superintendencia Financiera de Colombia (SFC), dio a conocer, para comentarios del público, la normativa con la cual busca impartir instrucciones para fortalecer la liquidez de los...more

Orrick, Herrington & Sutcliffe LLP

The Economic Crime and Corporate Transparency Act 2023: Identity Verification

Identity Verification (“IDV”) is a new process requiring individuals that run, own or control UK companies or limited liability partnerships (“LLPs”) to prove their identity to Companies House. IDV registration is voluntary...more

DLA Piper

AI in the Tech Sector – Touch Points and Regulatory Difference Across the EU and Australia

DLA Piper on

In the rapidly evolving tech industry sector, artificial intelligence (AI) stands at the forefront of innovation. Although stakeholders active in the technology sector represent the natural leaders of AI and are adopting AI...more

Sheppard Mullin Richter & Hampton LLP

New York Adopts Major Certificate of Need Amendments Effective August 6, 2025

On August 6, 2025, the New York State Department of Health (DOH) finalized amendments to its Certificate of Need (CON) regulations in 10 N.Y.C.R.R. Part 710, raising the financial thresholds for full review, expanding...more

A&O Shearman

UK CBA Panel issues statement on FCA's consultation paper on regulating BNPL products

A&O Shearman on

The Cost Benefit Analysis (CBA) Panel has issued a statement in response to the UK Financial Conduct Authority's (FCA) consultation paper on proposed rules to regulate Deferred Payment Credit (DPC) products, commonly known as...more

McGinnis Lochridge

Oil & Gas Newsletter: Producer's Edge, Vol. 7, Issue 1

McGinnis Lochridge on

The McGinnis Lochridge Oil and Gas Practice Group publishes the Producer’s Edge with the purpose of keeping our valued clients and contacts in the oil and gas industry updated and informed regarding interesting Texas case law...more

Holland & Knight LLP

A MOSAIC of Changes: Recent FAA Actions Promote Advanced Air Mobility

Holland & Knight LLP on

At the Experimental Aircraft Association's (EAA) annual EAA AirVenture Oshkosh, Wisconsin, on July 22, 2025, U.S. Department of Transportation Secretary Sean Duffy and Federal Aviation Administration (FAA) Deputy...more

A&O Shearman

FCA to launch new and improved Handbook website

A&O Shearman on

The UK Financial Conduct Authority (FCA) has announced its plan to launch a new and improved FCA Handbook website as part of its five-year strategy to enhance regulatory efficiency...more

Lowenstein Sandler LLP

Crypto Brief - Lowenstein Crypto Newsletter - July 3, 2025

On July 1, the Securities and Exchange Commission (SEC) Division of Corporation Finance issued guidance outlining disclosure expectations for crypto asset exchange-traded products, including both spot and derivative-based...more

Sheppard Mullin Richter & Hampton LLP

What’s Going on with Human Cell and Tissue Products?

Since the publication of our article on what to expect for stem cell regulation under the new administration, we’ve been closely monitoring the administration’s enhanced focus on the same....more

Bergeson & Campbell, P.C.

NIA Issues Position Paper on Divergent EU Approaches to Nano and Advanced Materials

On June 11, 2025, the Nanotechnology Industries Association (NIA) published a position paper entitled Bridging the Governance Gap: Divergent EU Approaches to Nano and Advanced Materials that highlights industry challenges...more

Orrick, Herrington & Sutcliffe LLP

What Does the ‘Big Beautiful Bill’ Mean for AI Regulation?

Budget reconciliation bill H.R.1, the “One Big Beautiful Bill Act,” currently pending in the U.S. Senate, includes not only tax and spending provisions but also a proposed five-year pause on state and local enforcement of...more

Troutman Pepper Locke

Federal “Temporary Pause” of State AI Laws Clears Procedural Hurdle as Sides Draw Battle Lines

Troutman Pepper Locke on

One of many provisions in the “One Big Beautiful Bill Act,” passed by the U.S. House of Representatives, would place a 10-year “temporary pause” on states’ ability to regulate artificial intelligence (AI). Initially called a...more

Mayer Brown

Novas Regras para Homologação e Operação dos Sistemas Free Flow nas Rodovias Brasileiras

Mayer Brown on

A Portaria Senatran nº 442/2025, publicada em 12 de junho de 2025, estabelece os procedimentos obrigatórios para homologação e interoperabilidade de sistemas de livre passagem (free flow) em rodovias de todo o território...more

Husch Blackwell LLP

FDA Launches Commissioner’s National Priority Voucher Program: What Life Sciences Innovators Need to Know

Husch Blackwell LLP on

On June 17, 2025, the Food and Drug Administration (FDA) announced the Commissioner’s National Priority Voucher (CNPV) program, a bold initiative designed to accelerate the review of therapies addressing critical national...more

Orrick, Herrington & Sutcliffe LLP

CFPB rescinds procedural rule on rulemaking

On June 18, the CFPB published a final rule in the Federal Register rescinding a previous rule that specified how the agency issues rules and when those rules are considered issued. Effective June 18, the final rule rescinds...more

A&O Shearman

ECB Decision (EU) 2025/1148 on access by Non-Bank Payment Service Providers to TARGET published in OJ

A&O Shearman on

The Decision (EU) 2025/1148 of the European Central Bank (ECB) adopted on 2 June, has been published in the Official Journal of the European Union. This decision amends Decision (EU) 2025/222 concerning access by non-bank...more

Hogan Lovells

FDA Commissioner’s National Priority Voucher program comes with questions surrounding implementation

Hogan Lovells on

The U.S. Food and Drug Administration (FDA) announced Tuesday a “Commissioner’s National Priority Voucher” (CNPV) program, which will provide a “limited number” of vouchers to sponsors of drug products that are “aligned with...more

A&O Shearman

EBA opinion on PSD2 and MiCAR

A&O Shearman on

The European Banking Authority (EBA) has issued an opinion (referred to as the No Action letter) in response to a request from the European Commission (EC) in December 2024, on the interplay between Payment Services Directive...more

43 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide